Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin’s Lymphoma (Q41597859)

4 October 2017

1 reference

title

Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma (English)

1 reference

4 October 2017

Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin’s Lymphoma (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

16 November 2024

C. Gisselbrecht

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9304703

16 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9304703

16 November 2024

publication date

1 January 1998

1 reference

4 October 2017

1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9304703

full work available at URL

16 November 2024

http://link.springer.com/content/pdf/10.1007/978-3-642-46836-0_3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Recent Results in Cancer Research

16 November 2024

published in

1 reference

4 October 2017

volume

144

1 reference

4 October 2017

page(s)

15-26

1 reference

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

hematopoietic stem cell transplantation

16 November 2024

283

J Baro

1991

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cells

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Results of MIME salvage regimen for recurrent or refractory lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Journal of Clinical Oncology

16 November 2024

399

CN Coleman

1986

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Pounding in the neck in supraventricular tachycardia

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multice

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

16 November 2024

1 reference

https://api.crossref.org/works/10.1007/978-3-642-46836-0_3

16 November 2024

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9304703

16 November 2024

1 reference